Philadelphia-positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID-19 pandemic: a Campus ALL study

Affiliations

¹ Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
³ Department of Hematology/Oncology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
⁴ Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
⁵ Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Torino, Italy.
⁶ Department of Medical Sciences, Section of Hematology, University of Ferrara, Ferrara, Italy.
⁷ Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Napoli, Italy.

Clinical Trial

Robin Foà et al. Br J Haematol. 2020 Jul.

. 2020 Jul;190(1):e3-e5.

doi: 10.1111/bjh.16758. Epub 2020 Jun 14.

¹ Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
³ Department of Hematology/Oncology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
⁴ Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
⁵ Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Torino, Italy.
⁶ Department of Medical Sciences, Section of Hematology, University of Ferrara, Ferrara, Italy.
⁷ Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Napoli, Italy.

No abstract available

Keywords: COVID-19; Ph+ acute lymphoblastic leukaemia; management; tyrosine kinase inhibitors.

References

1. Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi, P , et al. Clinico‐biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica. 2013;98:1702–10. - PMC - PubMed
1. Chiaretti S, Foà R. Management of adult Ph‐positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2015;2015:406–13. - PubMed
1. Vignetti M, Fazi P, Cimino G, Martinelli G, Di Raimondo F, Ferrara, F , et al. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome‐positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201‐B protocol. Blood. 2007;109:3676–8. - PubMed
1. Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris, M , et al. Dasatinib as first‐line treatment for adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia. Blood. 2011;118:6521–8. - PubMed
1. Chiaretti S, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo, C , et al. Dasatinib‐blinatumomab combination for the front‐line treatment of adult Ph+ ALL patients. Updated results of the GIMEMA LAL2116 D‐Alba trial. Blood. 2019;134:740.